Background: Interval contraception with Copper T 380A has been shown to be highly effective and reversible, providing ten years of reliable protection. Multiple studies have demonstrated that intra-caesarean implantation of an intrauterine contraceptive device (IUCD) is effective and poses no increased risk of infectious morbidity. Aim and Objectives: We aimed to study the clinical outcomes (safety, effectiveness, expulsion, and continuation rates) of post placental Copper T 380A insertion in women after cesarean section. Patients and methods: This case-control study was conducted in the Department of Obstetrics and Gynecology, AL-Azhar University Hospitals (Assiut), a Tertiary Care Hospital. The study included 67 pregnant women who were scheduled for elective Cesarean section. Results: The statistical significance (p-value< 0.001)) was extremely high increased percentage of lost follow at 6 months (19 patients, 39.6%) and 3 months (12 patients, 21.8%) when compared to 3 weeks (0 patients, 0%). Concerning the problems that were evaluated, there was no discernible difference (p value > 0.05) between the two time periods of follow-up. Conclusion: Intra caesarean IUCD insertion is a promising approach. It is safe and effective with remarkable low failure rate and minimal side effects over the users.